Abstract
Fibrolamellar hepatocellular carcinoma is an uncommon malignancy seen in young adults without underlying liver disease. Physical signs are minimal and laboratory values are noncontributory. Diagnosis is suggested by clinical history, supported by radiographic studies, and confirmed by histologic examination. Individuals with fibrolamellar carcinoma generally have a greater survival than those with hepatocellular carcinoma. Although most patients with fibrolamellar carcinoma undergo curative surgery, two of the three patients we report had inoperable tumors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Edmonson HA: Differential diagnosis of tumors and tumor-like lesion of liver in infancy and childhood. Arch Dis Child 91:168–186, 1956
Edmonson HA: Tumors of the liver and intrahepatic bile ducts.In Atlas of Tumor Pathology, Sect 7, Fasc. 25. Washington, DC, Armed Forces Institute of Pathology, 1958, p 98
Peters RL: Pathology of hepatocellular carcinoma.In Hepatocellular Carcinoma. K Okuda, R Peters (eds). New York, John Wiley & Sons, 1976, pp 107–166
Slavutin LJ, Diamond N: Case report. Hepatocellular carcinoma with lamellar fibrosis: An important histological variant. Pathology 13:775–781, 1981
Craig JR, Peters RL, Edmondson HA, Omata M: Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinicopathologic features. Cancer 46:372–379, 1980
Baithun SI, Pollock DJ: Oncocytic hepatocellular carcinoma. Histopathology 7:107–112, 1983
Berman MM, Libbey P, Foster JH: Hepatocellular carcinoma. Polygonal cell type with fibrous stroma—an atypical variant with a favorable prognosis. Cancer 46:1148–1155, 1980
Ang PT, Evans H, Pazdur R: Fibrolamellar hepatocellular carcinoma. Am J Clin Oncol 14:175–178, 1991
Albukerk J: Hepatocellular carcinoma in young adults. NY State J Med 81:1341–1344, 1981
Albaugh JS, Keeffe EB, Krippaehne WW: Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma. Dig Dis Sci 29:762–767, 1984
Lefkowitch JH, Muschel R, Price JB, Marboe C, Braunhut: Copper and copper-binding protein in fibrolamellar liver cell carcinoma. Cancer 51:97–100, 1983
An T, Ghatak N, Kastner R, Kay S, Lee HM: Hyaline globules and intracellular lumina in a hepatocellular carcinoma. Am J Clin Pathol 79:392–396, 1983
Wong LK, Link DP, Frey CF, Ruebner BH, Tesluk H, Pimstone NR: Fibrolamellar hepatocarcinoma: Radiology, management, and pathology. AJR 139:172–175, 1982
Ruffin MT: Fibrolamellar hepatoma. Am J Gastroenterol 85:577–581, 1990
Wetzel WJ, Costin JL, Petrino RL: Fibrolamellar carcinoma: Distinctive clinical and morphologic variant of hepatoma. South Med J 76:796–798, 1983
Goodman ZD: Case for diagnosis. Mil Med 147:778–779, 1982
McCloskey JJ, Germain-Lee EL, Perman JA, Plotnick LP: Gynecomastia as a presenting sign of fibrolamellar carcinoma of the liver. Pediatrics 82:379–382, 1988
Teitelbaum DH, Tuttle S, Carey LC, Clausen K: Fibrolamellar carcinoma of the liver. Ann Surg 202:36–41, 1985
Farhi DC, Shikes RH, Murari PJ, Silverberg SG: Hepatocellular carcinoma in young people. Cancer 52:1516–1525, 1983
Corrigan K, Semelka RC: Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma. Abdom Imaging 20:122–125, 1995
Chuong JJ, Livstone EM, Barwick KW: The histopathologic and clinical indicators of prognosis in hepatoma. J Clin Gastroenterol 4:547–552, 1982
Rustgi VK: Epidemiology of Hepatocellular carcinoma. Gastroenterol Clin North Am 16:545–551, 1987
Chlebowski RT, Tong M, Weissman J, Block, Ramming KP, Weiner JM, Batemean JR, Chlebowski JS: Hepatocellar carcinoma. Diagnostic and prognostic features in North American patients. Cancer 53:2701–2706, 1984
Beasley RP, Lin CC, Hwang LY, Chien CS: Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 2:1129–1132, 1981
Colombo M: Hepatocellular carcinoma. J Hepatol 15:225–236, 1992
Paradinas FJ, Melia WM, Wilkinson ML, Portmann B, Johnson PJ, Murray-Lyon IM, Williams R: High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J 285:840–842, 1982
Collier NA, Bloom SR, Hodgson HJ, Weinbren K, Lee YC, Blumgart: Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet 1:538–540, 1984
Soreide O, Zerniak A, Bradpiece H, Bloom S, Blumgart L: Characteristics of fibrolamellar hepatocellular carcinoma: A study of nine cases and a review of the literature. Am J Surg 151:518–523, 1986
Adam A, Gibson RN, Soreide O, Hemmingway WP, Carr DH, Blumgart LH, Allison DJ: The radiology of fibrolamellar hepatoma. Clin Radiol 37:355–358, 1986
Powers C, Ros PR, Stoupis C, Johnson WK, Segel KH: Primary liver neoplasms: MR imaging with pathologic correlation. Radiographics 14:459–482, 1994
Hamrick-Turner JE, Shipkey FH, Cranston PE: Case report. Fibrolamellar hepatocellular carcinoma: MR appearance mimicking focal nodular hyperplasia. J Comput Assisst Tomogi 18:301–304, 1994
Lack EE, Neave C, Vawter GF: Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 52:1510–1515, 1983
Ringe B, Wittekind C, Weimann A, Tusch G, Pichlmayr R. Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet 175:299–305, 1986
Starzl TE, Iwatsuki S, Shaw BW, Nalesnik MA, Garhi DC, Van Thiel DH: Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 162:145–148, 1986
Iwatsuki S, Starzl TE, Sheahan DG, Yokoyamal I, Demetris AJ Todo S, Tzakis AG, Van Thiel DH, Carr B, Selby R, Madariaga J: Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214:221–229, 1991
Ismail T, Angrisani L, Gunson BK, Hubscher SG, Buckels JAC, Neuberger JM, Elias JE, McMaster P: Primary hepatic malignancy: The role of liver transplantation. Br J Surg 77:983–987, 1990
Nagorney DM, Adson MA, Weiland LH, Knight CD Jr, Smalley SR, Zinsmeister AR: Fibrolamellar hepatoma. Am J Surg 149:113–119, 1985
Yokoyama I, Todo S, Iwatsuki I, Starzl TE: Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 37:188–193, 1990
Farmer DG, Rosove MH, Shaked A, Busutil RW: Current treatment modalities for hepatocellular carcinoma. Ann Surg 219:236–247, 1994
Tang ZY, Yu YQ, Zhou XD, Ma AC, Yang R, Lu JZ, Lin ZY, Yang BH: Surgery of small hepatocellular carcinoma. analysis of 144 cases. Cancer 64:536–541, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saab, S., Yao, F. Fibrolamellar hepatocellular carcinoma. Digest Dis Sci 41, 1981–1985 (1996). https://doi.org/10.1007/BF02093600
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02093600